Compounds > bencyclane
Page last updated: 2024-09-20

bencyclane

Description

Bencyclane: A vasodilator agent found to be effective in a variety of peripheral circulation disorders. It has various other potentially useful pharmacological effects. Its mechanism may involve block of calcium channels. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID2312
CHEMBL ID2110767
CHEBI ID135205
SCHEMBL ID64881
MeSH IDM0002307

Synonyms (40)

Synonym
bencyclane
2179-37-5
n,n-dimethyl-3-{[1-(phenylmethyl)cycloheptyl]oxy}propan-1-amine
D07500
bencyclane (inn)
bencyclanum [inn-latin]
1-propanamine, n,n-dimethyl-3-((1-(phenylmethyl)cycloheptyl)oxy)-
bencyclane [inn]
einecs 218-547-0
benciclano [inn-spanish]
3-((1-benzylcycloheptyl)oxy)-n,n-dimethylpropylamin
CHEBI:135205
benzcyclan
3-(1-benzylcycloheptyl)oxy-n,n-dimethylpropan-1-amine
6i97z6s135 ,
bencyclanum
benciclano
unii-6i97z6s135
SCHEMBL64881
tox21_113690
dtxsid0022646 ,
NCGC00249914-01
cas-2179-37-5
dtxcid002646
3-((1-benzylcycloheptyl)oxy)-n,n-dimethylpropylamine
bencyclane [mi]
bencyclane [who-dd]
1-propanamine, n,n-dimethyl-3-[[1-(phenylmethyl)cycloheptyl]oxy]-
3-[(1-benzylcycloheptyl)oxy]-n,n-dimethylpropylamine
FYJJXENSONZJRG-UHFFFAOYSA-N
n-(3-[(1-benzylcycloheptyl)oxy]propyl)-n,n-dimethylamine #
CHEMBL2110767
benzcyclane
bencyclan
HY-U00134
CS-7171
DB13488
Q723117
bencyclane; benzcyclan
AKOS040732567

Research Excerpts

Overview

ExcerptReference
"Bencyclane appears to be a promising anti-sickling agent that can be used orally in SCD."( Aikimbaev, KS; Başlamişli, F; Güvenç, B; Isbir, T; Koçak, R; Tamer, L, 1996)
"Bencyclane is a new myotropic substance."( Patel, VJ, 1978)

Drug Classes (1)

ClassDescription
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency21.13170.006038.004119,952.5996AID1159521
GLI family zinc finger 3Homo sapiens (human)Potency12.60820.000714.592883.7951AID1259369; AID1259392
retinoid X nuclear receptor alphaHomo sapiens (human)Potency8.48520.000817.505159.3239AID1159527
pregnane X nuclear receptorHomo sapiens (human)Potency26.60320.005428.02631,258.9301AID1346982
cytochrome P450 2D6Homo sapiens (human)Potency2.18760.00108.379861.1304AID1645840
thyroid stimulating hormone receptorHomo sapiens (human)Potency26.60320.001628.015177.1139AID1259385
activating transcription factor 6Homo sapiens (human)Potency26.83250.143427.612159.8106AID1159516
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency18.33460.057821.109761.2679AID1159526; AID1159528
Spike glycoproteinSevere acute respiratory syndrome-related coronavirusPotency35.48130.009610.525035.4813AID1479145
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
virion membraneSpike glycoproteinSevere acute respiratory syndrome-related coronavirus
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (31)

Assay IDTitleYearJournalArticle
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (144)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990121 (84.03)18.7374
1990's5 (3.47)18.2507
2000's8 (5.56)29.6817
2010's4 (2.78)24.3611
2020's6 (4.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials28 (17.39%)5.53%
Reviews4 (2.48%)6.00%
Case Studies9 (5.59%)4.05%
Observational0 (0.00%)0.25%
Other120 (74.53%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceDescriptionRelationhip StrengthStudiesTrialsClassesRoles
emoxypine succinate[no description available]medium20
beta-escin[no description available]medium10triterpenoid saponin
heme[no description available]medium10
thulium[no description available]medium10f-block element atom;
lanthanoid atom
dobutamine[no description available]medium10catecholamine;
secondary amine		beta-adrenergic agonist;
cardiotonic drug;
sympathomimetic agent
ibuprofen[no description available]medium10monocarboxylic acidantipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
radical scavenger;
xenobiotic
aspirin[no description available]medium61benzoic acids;
phenyl acetates;
salicylates		anticoagulant;
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
plant activator;
platelet aggregation inhibitor;
prostaglandin antagonist;
teratogenic agent
pentoxifylline[no description available]medium132oxopurine
clorazepate dipotassium[no description available]medium10potassium saltanticonvulsant;
anxiolytic drug;
GABA modulator;
prodrug
amitriptyline[no description available]medium10carbotricyclic compound;
tertiary amine		adrenergic uptake inhibitor;
antidepressant;
environmental contaminant;
tropomyosin-related kinase B receptor agonist;
xenobiotic
nitrazepam[no description available]medium101,4-benzodiazepinone;
C-nitro compound		anticonvulsant;
antispasmodic drug;
drug metabolite;
GABA modulator;
sedative
diazepam[no description available]medium101,4-benzodiazepinone;
organochlorine compound		anticonvulsant;
anxiolytic drug;
environmental contaminant;
sedative;
xenobiotic
imipramine[no description available]medium20dibenzoazepineadrenergic uptake inhibitor;
antidepressant;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
trimeprazine[no description available]medium10phenothiazines
promethazine[no description available]medium10phenothiazines;
tertiary amine		anti-allergic agent;
anticoronaviral agent;
antiemetic;
antipruritic drug;
H1-receptor antagonist;
local anaesthetic;
sedative
nalorphine[no description available]medium10morphinane alkaloid
papaverine[no description available]medium130benzylisoquinoline alkaloid;
dimethoxybenzene;
isoquinolines		antispasmodic drug;
vasodilator agent
naloxone[no description available]medium10morphinane alkaloid;
organic heteropentacyclic compound;
tertiary alcohol		antidote to opioid poisoning;
central nervous system depressant;
mu-opioid receptor antagonist
drotaverin[no description available]medium50isoquinolines
nafazatrom[no description available]medium10
mopidamol[no description available]medium40dialkylarylamine;
tertiary amino compound
dipyridamole[no description available]medium70piperidines;
pyrimidopyrimidine;
tertiary amino compound;
tetrol		adenosine phosphodiesterase inhibitor;
EC 3.5.4.4 (adenosine deaminase) inhibitor;
platelet aggregation inhibitor;
vasodilator agent
phosphorus radioisotopes[no description available]medium10
isoxsuprine[no description available]medium20alkylbenzene
norfenefrine[no description available]medium10phenols
carbachol[no description available]medium10ammonium salt;
carbamate ester		cardiotonic drug;
miotic;
muscarinic agonist;
nicotinic acetylcholine receptor agonist;
non-narcotic analgesic
phenolsulfonphthalein[no description available]medium102,1-benzoxathiole;
arenesulfonate ester;
phenols;
sultone		acid-base indicator;
diagnostic agent;
two-colour indicator
albuterol[no description available]medium10phenols;
phenylethanolamines;
secondary amino compound		beta-adrenergic agonist;
bronchodilator agent;
environmental contaminant;
xenobiotic
phenoxybenzamine[no description available]medium10aromatic amine
propranolol[no description available]medium30naphthalenes;
propanolamine;
secondary amine		anti-arrhythmia drug;
antihypertensive agent;
anxiolytic drug;
beta-adrenergic antagonist;
environmental contaminant;
human blood serum metabolite;
vasodilator agent;
xenobiotic
atropine[no description available]medium10
octopamine[no description available]medium10phenylethanolamines;
tyramines		neurotransmitter
galactose[no description available]medium10
buflomedil[no description available]medium32aromatic ketone
cinnarizine[no description available]medium83diarylmethane;
N-alkylpiperazine;
olefinic compound		anti-allergic agent;
antiemetic;
calcium channel blocker;
geroprotector;
H1-receptor antagonist;
histamine antagonist;
muscarinic antagonist
nicergoline[no description available]medium11organic heterotetracyclic compound;
organonitrogen heterocyclic compound
histamine[no description available]medium10aralkylamino compound;
imidazoles		human metabolite;
mouse metabolite;
neurotransmitter
vinpocetine[no description available]medium20alkaloidgeroprotector
dihydroergotoxine[no description available]medium10
adenosine diphosphate[no description available]medium90adenosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate		fundamental metabolite;
human metabolite
quinine[no description available]medium10cinchona alkaloidantimalarial;
muscle relaxant;
non-narcotic analgesic
egtazic acid[no description available]medium10diether;
tertiary amino compound;
tetracarboxylic acid		chelator
thromboplastin[no description available]medium20
fumarates[no description available]medium50butenedioate;
C4-dicarboxylate		human metabolite;
metabolite;
Saccharomyces cerevisiae metabolite
hydrogen[no description available]medium10elemental hydrogen;
elemental molecule;
gas molecular entity		antioxidant;
electron donor;
food packaging gas;
fuel;
human metabolite
theophylline[no description available]medium30dimethylxanthineadenosine receptor antagonist;
anti-asthmatic drug;
anti-inflammatory agent;
bronchodilator agent;
drug metabolite;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
fungal metabolite;
human blood serum metabolite;
immunomodulator;
muscle relaxant;
vasodilator agent
cyproheptadine[no description available]medium10piperidines;
tertiary amine		anti-allergic agent;
antipruritic drug;
gastrointestinal drug;
H1-receptor antagonist;
serotonergic antagonist
aminophylline[no description available]medium50mixturebronchodilator agent;
cardiotonic drug
isoproterenol[no description available]medium10catechols;
secondary alcohol;
secondary amino compound		beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
sympathomimetic agent
nad[no description available]medium10organophosphate oxoanioncofactor;
human metabolite;
hydrogen acceptor;
Saccharomyces cerevisiae metabolite
yohimbine[no description available]medium40methyl 17-hydroxy-20xi-yohimban-16-carboxylatealpha-adrenergic antagonist;
dopamine receptor D2 antagonist;
serotonergic antagonist
nafronyl[no description available]medium62naphthalenes
betahistine[no description available]medium11aminoalkylpyridine;
secondary amino compound		H1-receptor agonist;
vasodilator agent
medazepam[no description available]medium11organic molecular entity
retinol[no description available]medium11retinol;
vitamin A		human metabolite;
mouse metabolite;
plant metabolite
d-alpha tocopherol[no description available]medium11alpha-tocopherolalgal metabolite;
antiatherogenic agent;
anticoagulant;
antioxidant;
antiviral agent;
EC 2.7.11.13 (protein kinase C) inhibitor;
immunomodulator;
micronutrient;
nutraceutical;
plant metabolite
xanthinol niacinate[no description available]medium40
piribedil[no description available]medium20N-arylpiperazine
vincamine[no description available]medium10alkaloid ester;
hemiaminal;
methyl ester;
organic heteropentacyclic compound;
vinca alkaloid		antihypertensive agent;
metabolite;
vasodilator agent
quinacrine[no description available]medium10acridines;
aromatic ether;
organochlorine compound;
tertiary amino compound		antimalarial;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
chloroquine[no description available]medium10aminoquinoline;
organochlorine compound;
secondary amino compound;
tertiary amino compound		anticoronaviral agent;
antimalarial;
antirheumatic drug;
autophagy inhibitor;
dermatologic drug
adenosine monophosphate[no description available]medium20adenosine 5'-phosphate;
purine ribonucleoside 5'-monophosphate		adenosine A1 receptor agonist;
cofactor;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
EC 3.1.3.11 (fructose-bisphosphatase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical
nicotinyl alcohol[no description available]medium20aromatic primary alcohol;
pyridines		antilipemic drug;
vasodilator agent
cinanserin[no description available]medium10aryl sulfide;
cinnamamides;
secondary carboxamide;
tertiary amino compound		anticoronaviral agent;
antiviral agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor
thiophenes[no description available]medium10mancude organic heteromonocyclic parent;
monocyclic heteroarene;
thiophenes;
volatile organic compound		non-polar solvent
calcium dobesilate[no description available]medium10
theobromine[no description available]medium20dimethylxanthineadenosine receptor antagonist;
bronchodilator agent;
food component;
human blood serum metabolite;
mouse metabolite;
plant metabolite;
vasodilator agent
xenon[no description available]medium11monoatomic xenon;
noble gas atom;
p-block element atom
pindolol[no description available]medium10indoles;
secondary amine		antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist;
serotonergic antagonist;
vasodilator agent
hydrochlorothiazide[no description available]medium10benzothiadiazine;
organochlorine compound;
sulfonamide		antihypertensive agent;
diuretic;
environmental contaminant;
xenobiotic
digoxin[no description available]medium21cardenolide glycoside;
steroid saponin		anti-arrhythmia drug;
cardiotonic drug;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
epitope
hexobendine[no description available]medium10trihydroxybenzoic acid
pyrithioxin[no description available]medium20methylpyridines
meclofenoxate[no description available]medium20monocarboxylic acid
lidoflazine[no description available]medium10diarylmethane
dihydroxyphenylalanine[no description available]medium10hydroxyphenylalanine;
non-proteinogenic alpha-amino acid;
tyrosine derivative		human metabolite
fibrinogen[no description available]medium10iditolfungal metabolite
nitrous oxide[no description available]medium10gas molecular entity;
nitrogen oxide		analgesic;
bacterial metabolite;
food packaging gas;
food propellant;
general anaesthetic;
greenhouse gas;
inhalation anaesthetic;
NMDA receptor antagonist;
raising agent;
refrigerant;
vasodilator agent
halothane[no description available]medium10haloalkane;
organobromine compound;
organochlorine compound;
organofluorine compound		inhalation anaesthetic
xenon radioisotopes[no description available]medium10
chloracizine[no description available]medium10
halofenate[no description available]medium10
metaproterenol[no description available]medium10aralkylamino compound;
phenylethanolamines;
resorcinols;
secondary alcohol;
secondary amino compound
bendazole[no description available]medium10benzimidazoles
2,2,4-trimethylpentane[no description available]medium10alkane;
volatile organic compound		fuel additive;
nephrotoxin;
non-polar solvent
phosphorus[no description available]medium10monoatomic phosphorus;
nonmetal atom;
pnictogen		macronutrient
octane[no description available]medium10alkanexenobiotic
veratrine[no description available]medium10alkaloid
deanol[no description available]medium10ethanolamines;
tertiary amine		curing agent;
radical scavenger
2,4-dichlorophenoxyacetic acid[no description available]medium10chlorophenoxyacetic acid;
dichlorobenzene		agrochemical;
defoliant;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
environmental contaminant;
phenoxy herbicide;
synthetic auxin
4-chlorophenoxyacetic acid[no description available]medium10chlorophenoxyacetic acid;
monochlorobenzenes		phenoxy herbicide
flunarizine[no description available]medium21diarylmethane
prenylamine[no description available]medium10diarylmethane
fendiline[no description available]medium10diarylmethane
gallopamil[no description available]medium10benzenes;
organic amino compound
bepridil[no description available]medium10pyrrolidines;
tertiary amine		anti-arrhythmia drug;
antihypertensive agent;
calcium channel blocker;
vasodilator agent
verapamil[no description available]medium10aromatic ether;
nitrile;
polyether;
tertiary amino compound
diltiazem[no description available]medium105-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetateantihypertensive agent;
calcium channel blocker;
vasodilator agent
nimodipine[no description available]medium102-methoxyethyl ester;
C-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
isopropyl ester		antihypertensive agent;
calcium channel blocker;
cardiovascular drug;
vasodilator agent
nifedipine[no description available]medium10C-nitro compound;
dihydropyridine;
methyl ester		calcium channel blocker;
human metabolite;
tocolytic agent;
vasodilator agent
prednisolone[no description available]medium1011beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
drug metabolite;
environmental contaminant;
immunosuppressive agent;
xenobiotic
piperidines[no description available]medium10
dipyrone[no description available]medium10organic sodium saltanti-inflammatory agent;
antipyretic;
antirheumatic drug;
cyclooxygenase 3 inhibitor;
non-narcotic analgesic;
peripheral nervous system drug;
prodrug
aminopyrine[no description available]medium10pyrazolone;
tertiary amino compound		antipyretic;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
2-propanol[no description available]medium20secondary alcohol;
secondary fatty alcohol		protic solvent
eye[no description available]medium20
3-phenylpropionic acid[no description available]low00benzenes;
monocarboxylic acid		antifungal agent;
human metabolite;
plant metabolite
benzene[no description available]low00aromatic annulene;
benzenes;
volatile organic compound		carcinogenic agent;
environmental contaminant;
non-polar solvent
phenylacetic acid[no description available]low00benzenes;
monocarboxylic acid;
phenylacetic acids		allergen;
Aspergillus metabolite;
auxin;
EC 6.4.1.1 (pyruvate carboxylase) inhibitor;
Escherichia coli metabolite;
human metabolite;
plant growth retardant;
plant metabolite;
Saccharomyces cerevisiae metabolite;
toxin
mandelic acid[no description available]low002-hydroxy monocarboxylic acid;
benzenes		antibacterial agent;
human xenobiotic metabolite
4-phenyl-3-furoxancarbonitrile[no description available]low001,2,5-oxadiazole;
benzenes;
N-oxide;
nitrile		geroprotector;
nitric oxide donor;
platelet aggregation inhibitor;
soluble guanylate cyclase activator;
vasodilator agent
benzamidine[no description available]low00benzenes;
carboxamidine		serine protease inhibitor
benzyl isothiocyanate[no description available]low00benzenes;
isothiocyanate		antibacterial drug
benzylhydrochlorothiazide[no description available]low00benzenes;
benzothiadiazine;
organochlorine compound;
secondary amino compound;
sulfonamide
carbetapentane[no description available]low00benzenes
carbidopa[no description available]low00benzenes;
monocarboxylic acid
cetraxate[no description available]low00benzenes;
monocarboxylic acid
chlorpropham[no description available]low00benzenes;
carbamate ester;
monochlorobenzenes		herbicide;
plant growth retardant
cimaterol[no description available]low00benzenes;
nitrile
clofilium[no description available]low00benzenes;
organic amino compound
diphenidol[no description available]low00benzenes;
piperidines;
tertiary alcohol		antiemetic
cycloadiphenine[no description available]low00benzenes
fenipentol[no description available]low00benzenes
2-cyclopentyl-2-hydroxy-2-phenylacetic acid (1,1-dimethyl-3-pyrrolidin-1-iumyl) ester[no description available]low00benzenes
lidocaine[no description available]low00benzenes;
monocarboxylic acid amide;
tertiary amino compound		anti-arrhythmia drug;
drug allergen;
environmental contaminant;
local anaesthetic;
xenobiotic
isocarboxazid[no description available]low00benzenes
labetalol[no description available]low00benzamides;
benzenes;
phenols;
primary carboxamide;
salicylamides;
secondary alcohol;
secondary amino compound
methadone[no description available]low00benzenes;
diarylmethane;
ketone;
tertiary amino compound
3-Hydroxy-alpha-methyl-DL-tyrosine[no description available]low00benzenes;
monocarboxylic acid
metolachlor[no description available]low00aromatic amide;
benzenes;
ether;
organochlorine compound
nafoxidine[no description available]low00benzenes;
naphthalenes;
ring assembly
nicardipine[no description available]low00benzenes;
C-nitro compound;
diester;
dihydropyridine;
methyl ester;
tertiary amino compound
phenprobamate[no description available]low00benzenes
sulfabenzamide[no description available]low00benzenes;
sulfonamide antibiotic;
sulfonamide		antibacterial drug;
antimicrobial drug
sulfacytine[no description available]low00benzenes;
sulfonamide
sulfamonomethoxine[no description available]low00benzenes;
sulfonamide
sulfaquinoxaline[no description available]low00benzenes;
sulfonamide
2-phenylcyclopropan-1-amine[no description available]low00benzenes;
cyclopropanes;
primary amine
tyropanoate[no description available]low00benzenes;
monocarboxylic acid
tolazoline hydrochloride[no description available]low00benzenes
phenylethyl alcohol[no description available]low00benzenes;
primary alcohol		Aspergillus metabolite;
fragrance;
plant growth retardant;
plant metabolite;
Saccharomyces cerevisiae metabolite
mebanazine[no description available]low00benzenes
phencyclidine[no description available]low00benzenes;
piperidines		anaesthetic;
neurotoxin;
NMDA receptor antagonist;
psychotropic drug
caramiphen[no description available]low00benzenes
acetyl sulfisoxazole[no description available]low00benzenes;
sulfonamide
2-phenylbutyric acid[no description available]low00benzenes;
monocarboxylic acid		human xenobiotic metabolite
diphenyl[no description available]low00aromatic fungicide;
benzenes;
biphenyls		antifungal agrochemical;
antimicrobial food preservative
styrene glycol[no description available]low00benzenes
sulfaethidole[no description available]low00benzenes;
sulfonamide
iophenoxic acid[no description available]low00benzenes;
monocarboxylic acid
benzotrichloride[no description available]low00benzenes;
organochlorine compound;
volatile organic compound		carcinogenic agent
benzal chloride[no description available]low00benzenes
benzoyl chloride[no description available]low00acyl chloride;
benzenes		carcinogenic agent
benzonitrile[no description available]low00benzenes;
nitrile
methylphenylsulfide[no description available]low00aryl sulfide;
benzenes
methyl phenylacetate[no description available]low00benzenes
ethyl phenylacetate[no description available]low00benzenes
phenyl isocyanate[no description available]low00benzenes;
isocyanates		allergen;
hapten
3-phenylpropanal[no description available]low00aldehyde;
benzenes		flavouring agent;
plant metabolite
1,4-diethylbenzene[no description available]low00benzenes
benzyl cyanide[no description available]low00benzenes;
nitrile		animal metabolite;
pheromone
pivalylbenzhydrazine[no description available]low00benzenes
mexacarbate[no description available]low00benzenes
carbutamide[no description available]low00benzenes;
sulfonamide
methaphenilene[no description available]low00benzenes
biphenylacetylene[no description available]low00arylacetylene;
benzenes		fluorochrome
beclamide[no description available]low00benzenes
mepiperphenidol[no description available]low00benzenes;
organic amino compound
glybuthiazol[no description available]low00benzenes;
sulfonamide
phenylacetylene[no description available]low00benzenes
sulfanilylurea[no description available]low00benzenes;
sulfonamide
metahexamide[no description available]low00benzenes;
sulfonamide
nitrosobenzene[no description available]low00benzenes;
nitroso compound		xenobiotic metabolite
triphenylphosphine[no description available]low00benzenes;
tertiary phosphine		NMR chemical shift reference compound;
reducing agent
2-cyanophenol[no description available]low00benzenes;
nitrile
bensulide[no description available]low00benzenes
1-phenylcyclohex-1-ene[no description available]low00benzenes
diphenyl disulfide[no description available]low00benzenes
2-phenylpropanol[no description available]low00benzenes
methyl phenyl sulfoxide[no description available]low00benzenes;
sulfoxide
2,6-dimethoxybenzoic acid[no description available]low00benzenes;
carbonyl compound
phenylphosphonic acid[no description available]low00benzenes
pyrazon[no description available]low00benzenes;
organochlorine compound;
primary amino compound;
pyridazinone		environmental contaminant;
herbicide;
xenobiotic
3-phenylpropylamine[no description available]low00benzenes;
phenylalkylamine;
primary amino compound
aminorex[no description available]low00benzenes
5-phenylvaleric acid[no description available]low00benzenes;
monocarboxylic acid
bitoscanate[no description available]low00benzenes
3-phenylbutyric acid[no description available]low00benzenes;
monocarboxylic acid		antibacterial agent;
bacterial xenobiotic metabolite
teclozan[no description available]low00benzenes
dioxacarb[no description available]low00benzenes
fenestrel[no description available]low00benzenes
propham[no description available]low00benzenes;
carbamate ester		herbicide;
plant growth retardant
cyanophenphos[no description available]low00benzenes;
nitrile
N'-methyl-N,N-diphenylurea[no description available]low00benzenes
dibenzo-18-crown-6[no description available]low00benzenes;
crown ether		phase-transfer catalyst
clobutinol[no description available]low00benzenes;
organic amino compound
phenyl acetate[no description available]low00benzenes;
phenyl acetates
ripazepam[no description available]low00benzenes
u 40481[no description available]low00benzenes;
formamidines		marine xenobiotic metabolite
iprodione[no description available]low00benzenes;
dichlorophenyl dicarboximide fungicide;
imidazole fungicide;
imidazolidine-2,4-dione;
ureas		antifungal agrochemical;
nematicide
clorsulon[no description available]low00benzenes;
sulfonamide
ibutilide[no description available]low00benzenes;
organic amino compound
prosulfocarb[no description available]low00benzenes;
monothiocarbamic ester		environmental contaminant;
herbicide;
xenobiotic
Isopropyl phenylacetate[no description available]low00benzenes
4-methyl-1-phenylpentan-2-ol[no description available]low00benzenes
magnesium salicylate[no description available]low00benzenes;
carbonyl compound
plerixafor[no description available]low00azacycloalkane;
azamacrocycle;
benzenes;
crown amine;
secondary amino compound;
tertiary amino compound		anti-HIV agent;
antineoplastic agent;
C-X-C chemokine receptor type 4 antagonist;
immunological adjuvant
tribuzone[no description available]low00benzenes
phenylpropiolic acid[no description available]low00acetylenic compound;
alpha,beta-unsaturated monocarboxylic acid;
benzenes
2-Oxo-4-phenylbutyric acid[no description available]low00benzenes
emopamil[no description available]low00benzenes;
organic amino compound
bathophenanthroline[no description available]low00benzenes;
phenanthrolines		chelator
2-aminobenzenesulfonamide[no description available]low00benzenes;
sulfonamide
3-phenylpropyl isothiocyanate[no description available]low00benzenes
4-chloro-5-sulfamoylanthranilic acid[no description available]low00benzenes;
sulfonamide
phenylheptatriyne[no description available]low00benzenes
methyl mandelate[no description available]low00benzenes
benzylphosphonic acid[no description available]low00benzenes
9,10-bis(phenylethynyl)anthracene[no description available]low00anthracenes;
arylacetylene;
benzenes		fluorochrome
4-phenylbutylamine[no description available]low00benzenes;
phenylalkylamine;
primary amino compound
3-(4'-hydroxyl-3',5'-dimethoxyphenyl)propionic acid[no description available]low00benzenes;
monocarboxylic acid
sdds[no description available]low00benzenes;
sulfonamide
1-hydroxy-1-phenyl-2-propanone[no description available]low00benzenes;
methyl ketone;
secondary alpha-hydroxy ketone
silomat[no description available]low00benzenes;
organic amino compound
phenylisopropyladenosine[no description available]low00aromatic amine;
benzenes;
hydrocarbyladenosine;
purine nucleoside;
secondary amino compound		adenosine A1 receptor agonist;
neuroprotective agent
alpha-Cyclohexylmandelic acid[no description available]low00benzenes
1-amino-1-phenylmethyl phosphonic acid[no description available]low00benzenes;
phosphonic acids;
primary amino compound
alpha-methylphenylalanine[no description available]low00benzenes;
monocarboxylic acid
piscidic acid[no description available]low00benzenes;
monocarboxylic acid
mitiglinide[no description available]low00benzenes;
monocarboxylic acid
n-(4-(7-diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide[no description available]low00benzenes;
coumarins;
maleimides;
tertiary amino compound		fluorescent dye
4-phenylbutyl isothiocyanate[no description available]low00benzenes;
organic amino compound
n-acetylphenelzine[no description available]low00benzenes
forasartan[no description available]low00benzenes;
pyridines;
tetrazoles;
triazoles		angiotensin receptor antagonist;
antihypertensive agent
desethyloxybutynin[no description available]low00benzenes
varespladib[no description available]low00aromatic ether;
benzenes;
dicarboxylic acid monoamide;
indoles;
monocarboxylic acid;
primary carboxamide		anti-inflammatory drug;
antidote;
EC 3.1.1.4 (phospholipase A2) inhibitor
3,5-dihydroxyphenylpropionic acid[no description available]low00benzenes;
monocarboxylic acid
fukiic acid[no description available]low00benzenes;
monocarboxylic acid
monodesmethylcitalopram[no description available]low00benzenes;
organic amino compound
cyclodrine[no description available]low00benzenes
didesmethylcitalopram[no description available]low00benzenes;
organic amino compound
carlina oxide[no description available]low00benzenes
4-butyl-4-(hydroxymethyl)-1,2-diphenylpyrazolidine-3,5-dione[no description available]low00benzenes
2-[(3-oxo-1-cyclohexenyl)amino]benzonitrile[no description available]low00benzenes;
nitrile
benzyl d-glucopyranoside[no description available]low00benzenes;
beta-D-glucoside		plant metabolite
cafenstrole[no description available]low00benzenes;
sulfone;
triazoles		agrochemical;
antimitotic;
herbicide
(5-Phenyl-1,2,4-triazol-3-yl)urea[no description available]low00benzenes
pifithrin mu[no description available]low00benzenes
2-(2-phenylethyl)chromone[no description available]low00benzenes;
chromones		plant metabolite
bms 214662[no description available]low00benzenes;
benzodiazepine;
imidazoles;
nitrile;
sulfonamide;
thiophenes		antineoplastic agent;
apoptosis inducer;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor
N-bis(N-methylanilino)phosphoryl-N-methylaniline[no description available]low00benzenes
3-[di(propan-2-yl)phosphorylmethyl]benzonitrile[no description available]low00benzenes;
nitrile
4,5-diphenyl-1,2,3-triazole[no description available]low00benzenes;
ring assembly;
triazoles
N-benzylquinazolin-4-amine[no description available]low00benzenes;
quinazolines;
secondary amino compound
2-acetyl-6-amino-8-(2-phenylethyl)-1,3,8,8a-tetrahydroisoquinoline-5,7,7-tricarbonitrile[no description available]low00benzenes
thiobenzamide[no description available]low00benzenes
4-(benzylsulfanyl)thieno[2,3-d]pyrimidine[no description available]low00aryl sulfide;
benzenes;
thienopyrimidine
4-[(4-chloro-5-dithiazolylidene)amino]benzonitrile[no description available]low00benzenes;
nitrile
N-methyl-N-phenylthiourea[no description available]low00benzenes
3,6-dibenzyl-1,2-dihydro-1,2,4,5-tetraazine[no description available]low00benzenes
1-cyclohexyl-3-(2-phenylethyl)urea[no description available]low00benzenes
5-ethyl-1-(phenylmethyl)-1,3,5-triazinane-2-thione[no description available]low00benzenes
4-amino-N-(4-ethoxyphenyl)benzenesulfonamide[no description available]low00benzenes;
sulfonamide
N-[5-(phenylmethyl)-1,3,4-thiadiazol-2-yl]carbamic acid methyl ester[no description available]low00benzenes
1,3-bis(2-phenylethyl)thiourea[no description available]low00benzenes
8-methyl-2-phenyl-1,2,4-triazaspiro[4.5]decane-3-thione[no description available]low00benzenes
3-(4-ethyl-5-methyl-3-thiophenyl)-4-(phenylmethyl)-1H-1,2,4-triazole-5-thione[no description available]low00benzenes
4-(phenylmethyl)-3-(5-propyl-3-thiophenyl)-1H-1,2,4-triazole-5-thione[no description available]low00benzenes
6-(2-phenylethyl)-3-(phenylmethyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole[no description available]low00benzenes;
triazolothiadiazole
4-(2-furanylmethyl)-3-(phenylmethyl)-1H-1,2,4-triazole-5-thione[no description available]low00benzenes
4-(1H-imidazol-1-ylmethyl)benzonitrile[no description available]low00benzenes;
nitrile
N-(3-cyano-5-methyl-4-phenyl-2-thiophenyl)-3,5-dimethyl-4-isoxazolecarboxamide[no description available]low00benzenes
1-amino-3-[3-(2-sulfanylidene-3H-1,3,4-oxadiazol-5-yl)phenyl]thiourea[no description available]low00benzenes
N-(3-phenylpropyl)methanesulfonamide[no description available]low00benzenes
1-ethyl-3-[[[(phenylmethyl)amino]-sulfanylidenemethyl]amino]thiourea[no description available]low00benzenes
N-[[(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)amino]-sulfanylidenemethyl]-5-methyl-3-phenyl-4-isoxazolecarboxamide[no description available]low00benzenes
amn082[no description available]low00benzenes;
diamine;
diarylmethane;
secondary amino compound		metabotropic glutamate receptor agonist;
neuroprotective agent
2-(2-furanyl)-3,5-dimethyl-4-oxido-6-phenylpyrazin-1-ium 1-oxide[no description available]low00benzenes
N-(3,4-dihydro-2H-pyrrol-5-yl)-5-phenyl-1,3,4-oxadiazol-2-amine[no description available]low00benzenes
4-butyl-3-(phenylmethyl)-1H-1,2,4-triazole-5-thione[no description available]low00benzenes
N1-phenethylhydrazine-1-carbothioamide[no description available]low00benzenes
1-hydroxy-5,5-dimethyl-2-phenyltetrahydro-4H-imidazole-4-thione[no description available]low00benzenes
2-[1-[2-oxo-2-[(4-thiophen-2-ylphenyl)methylamino]ethyl]cyclohexyl]acetic acid[no description available]low00benzenes
5-[4-(2-furylcarbonyl)piperazino]-5-oxo-3-phenylpentanoic acid[no description available]low00benzenes;
monocarboxylic acid
N-(cyclopropylmethyl)-N'-phenylurea[no description available]low00benzenes
2-[(4-chlorophenyl)methoxy]-6-methoxybenzonitrile[no description available]low00benzenes;
nitrile
2-(4-pentylphenyl)acetic acid[no description available]low00benzenes
5-methyl-2-phenyl-5-(2-phenylethyl)-1,2,4-triazolidine-3-thione[no description available]low00benzenes
k 858[no description available]low00benzenes
4-[[[4-(2-furanylmethyl)-5-(thiophen-2-ylmethyl)-1,2,4-triazol-3-yl]thio]methyl]benzonitrile[no description available]low00benzenes;
nitrile
9-oxo-N-(1-phenylethyl)-3-bicyclo[3.3.1]nonanecarboxamide[no description available]low00benzenes
N1,N4-bis(1-phenylethyl)cyclohexane-1,4-dicarboxamide[no description available]low00benzenes
4-phenyl-3H-thiazole-2-thione[no description available]low00benzenes
sulfatolamide[no description available]low00benzenes;
sulfonamide
ifetroban[no description available]low00benzenes;
monocarboxylic acid
1-[(2-ethyl-4-hydroxy-4-methyl-1-oxopentyl)amino]-3-phenylthiourea[no description available]low00benzenes
2-[6-amino-5-cyano-4-(4-ethylphenyl)-2,4-dihydropyrano[2,3-c]pyrazol-3-yl]acetic acid methyl ester[no description available]low00benzenes;
pyranopyrazole
3-phenyl-3-(1-tetrazolyl)propanoic acid[no description available]low00benzenes;
monocarboxylic acid
3,5-dimethyl-N-(2-phenylethyl)-N-(phenylmethyl)-4-isoxazolesulfonamide[no description available]low00benzenes
4-(2,3-dihydro-1,4-benzodioxin-3-ylmethylamino)-3-nitrobenzenesulfonamide[no description available]low00benzenes;
sulfonamide
N'-[5-(phenylmethyl)-4,5-dihydrothiazol-2-yl]hexanehydrazide[no description available]low00benzenes
5-amino-2-(diethylamino)-N-(2-methoxyphenyl)benzenesulfonamide[no description available]low00benzenes;
sulfonamide
4-(1-phenylethyl)-3-(5-propyl-3-thiophenyl)-1H-1,2,4-triazole-5-thione[no description available]low00benzenes
4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione[no description available]low00benzenes;
thiadiazolidine		anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
neuroprotective agent
N-[[(3-cyano-6-methyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)amino]-sulfanylidenemethyl]-5-methyl-3-phenyl-4-isoxazolecarboxamide[no description available]low00benzenes
N-[2-(4-methoxyphenyl)ethyl]-2-nitro-4-(1-pyrrolidinylsulfonyl)aniline[no description available]low00benzenes;
sulfonamide
1-(1-adamantyl)-3-[1-(phenylmethyl)-4-pyrazolyl]urea[no description available]low00benzenes
neticonazole[no description available]low00aromatic ether;
benzenes;
conazole antifungal drug;
enamine;
imidazole antifungal drug;
imidazoles;
methyl sulfide		antifungal drug;
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor
l796778[no description available]low00benzenes;
C-nitro compound;
L-lysine derivative;
L-phenylalanine derivative;
methyl ester;
oligopeptide;
secondary carboxamide;
ureas		somatostatin receptor agonist
l803087[no description available]low00benzenes;
fluoroindole;
guanidines;
L-arginine derivative;
methyl ester;
phenylindole;
secondary carboxamide		somatostatin receptor agonist
ro 4-6790[no description available]low00benzenes;
sulfonamide
bay 11-7085[no description available]low00benzenes;
nitrile;
sulfone		anti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
ferroptosis inducer;
NF-kappaB inhibitor
gluconasturtiin[no description available]low00aralkylglucosinolic acid;
benzenes
DPI2[no description available]low00benzenes;
morpholines;
secondary carboxamide;
tertiary amino compound;
thiazolidinone		ferroptosis inducer
l 744832[no description available]low00benzenes;
ether;
isopropyl ester;
secondary carboxamide;
sulfone;
thiol		antineoplastic agent;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor;
geroprotector
glucotropeolin[no description available]low00aralkylglucosinolic acid;
benzenes
5-(4-phenylbutoxy)psoralen[no description available]low00aromatic ether;
benzenes;
psoralens		geroprotector;
immunosuppressive agent;
potassium channel blocker
ro 25-6981[no description available]low00benzenes;
phenols;
piperidines;
secondary alcohol;
tertiary amino compound		anticonvulsant;
antidepressant;
neuroprotective agent;
NMDA receptor antagonist
bm 567[no description available]low00benzenes;
sulfonamide
varespladib methyl[no description available]low00aromatic ether;
benzenes;
indoles;
methyl ester;
primary carboxamide		anti-inflammatory drug;
antidote;
EC 3.1.1.4 (phospholipase A2) inhibitor;
prodrug
npi 2358[no description available]low002,5-diketopiperazines;
benzenes;
imidazoles;
olefinic compound		angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
microtubule-destabilising agent
chlorobactene[no description available]low00benzenes;
carotenoid phi-end group;
carotenoid		bacterial metabolite
ws-5995 c[no description available]low00benzenes;
naphthalenes;
ring assembly
phevalin[no description available]low00benzenes;
pyrazinone		bacterial metabolite;
calpain inhibitor
np 031112[no description available]low00benzenes;
naphthalenes;
thiadiazolidine		anti-inflammatory agent;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
neuroprotective agent
ym 216391[no description available]low001,3-oxazoles;
1,3-thiazoles;
azamacrocycle;
benzenes;
heterodetic cyclic peptide		antineoplastic agent;
bacterial metabolite
3-(4-nitrophenyl)-N-(4-phenylbutyl)-5-(phenylmethyl)-4,6-dihydro-3aH-pyrrolo[3,4-d]isoxazole-6a-carboxamide[no description available]low00benzenes;
organic amino compound
SYC-435[no description available]low00benzenes;
cyclic hydroxamic acid;
pyridone		antineoplastic agent;
EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor
trelagliptin[no description available]low00benzenes;
nitrile
1-hydroxy-5-nitro-N-(2-phenylethyl)-4-spiro[benzimidazole-2,1'-cyclohexane]imine[no description available]low00benzenes
5-methyl-5-pentyl-2-phenyl-1,2,4-triazolidine-3-thione[no description available]low00benzenes
N-methyl-3-[5-(3-phenylpropyl)-1,3,4-oxadiazol-2-yl]-N-(3-thiophenylmethyl)propanamide[no description available]low00benzenes
(5S)-1-(4-cyclohexylbutyl)-5-phenyl-4,5-dihydroimidazol-2-amine[no description available]low00benzenes
phenylmercuric acetate[no description available]low00arylmercury compound;
benzenes
sm 164[no description available]low00benzenes;
organic heterobicyclic compound;
secondary carboxamide;
triazoles		antineoplastic agent;
apoptosis inducer;
radiosensitizing agent
5-Methyl-1-phenyl-3-hexanyl sulfamate[no description available]low00benzenes
1-(3-methoxyphenyl)-3-(4-phenylbutyl)urea[no description available]low00benzenes;
organic amino compound
niraparib[no description available]low00benzenes;
indazoles;
piperidines;
primary carboxamide		antineoplastic agent;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
n-alpha-benzoyl-n5-(2-chloro-1-iminoethyl)-l-ornithine amide[no description available]low00benzenes
1,1,1,2,2-pentafluoro-7-phenylheptan-3-one[no description available]low00benzenes
3-[[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-1,4-diazepan-1-yl]sulfonyl]aniline[no description available]low00benzenes;
sulfonamide
difenacoum[no description available]low00benzenes;
naphthalenes;
ring assembly
warfarin[no description available]low00benzenes;
hydroxycoumarin;
methyl ketone
bromfenacoum[no description available]low00benzenes;
naphthalenes;
ring assembly
flocoumafen[no description available]low00benzenes;
naphthalenes;
ring assembly
gsk2879552[no description available]low00benzenes;
benzoic acids;
cyclopropanes;
monocarboxylic acid;
piperidines;
secondary amino compound;
tertiary amino compound		antineoplastic agent;
EC 1.14.99.66 (lysine-specific histone demethylase 1A) inhibitor
ConditionIndicatedRelationship StrengthStudiesTrials
A-V Dissociation0medium11
Abdominal Cramps0low10
Abdominal Migraine0low20
Abnormality, Heart0low10
Acid-Base Imbalance0low10
Acoustic Trauma0medium11
Acute Brain Injuries0low10
Acute Confusional Migraine0low20
Acute Disease0medium31
Amentia0low10
Anemia, Sickle Cell0low10
Angina Pectoris0low20
Angiohemophilia0low10
Angioma0low10
Angor Pectoris0low20
Anoxemia0low10
Anoxia0low10
Anoxia, Brain0low10
Anoxia, Cerebral0low10
Anoxic Brain Damage0low10
Anoxic Encephalopathy0low10
Anterior Circulation Transient Ischemic Attack0low10
Arterial Obstructive Diseases0medium129
Arterial Occlusive Diseases0medium129
Arteriosclerosis0low10
Arteriosclerosis Obliterans0low10
Aseptic Necrosis of Femur Head0low10
Asthma0low10
Asthma, Bronchial0low10
Atrioventricular Dissociation0medium11
Aura0low20
Auriculo-Ventricular Dissociation0medium11
Autosomal Hemophilia A0low10
Avascular Necrosis Of Femoral Head, Primary0low10
Avascular Necrosis of Femur Head0low10
Awakening Epilepsy0low20
Benign Neoplasms0low10
Blood Clot0medium31
Blood Coagulation Disorders0low10
Blood Platelet Disorders0low20
Blood Pressure, High0low20
Bradyarrhythmia0medium21
Bradyarrhythmias0medium21
Bradycardia0medium21
Brain Anoxia0low10
Brain Concussion0low10
Brain Edema0low10
Brain Hypoxia0low10
Brain Injuries0low10
Brain Injuries, Acute0low10
Brain Injuries, Focal0low10
Brain Ischemia0medium41
Brain Lacerations0low10
Brain Stem Ischemia, Transient0low10
Brain Stem Transient Ischemic Attack0low10
Brain Swelling0low10
Brain TIA0low10
Brain Vascular Disorders0medium104
Brainstem Ischemia, Transient0low10
Brainstem Transient Ischemic Attack0low10
Bronchial Asthma0low10
Cancer0low10
Cancer of Liver0low10
Cancer of Lung0low10
Cancer of the Liver0low10
Cancer of the Lung0low10
Cancer, Hepatocellular0low10
Carcinoma 256, Walker0low30
Carcinoma, Ehrlich Tumor0low10
Carcinosarcoma 256, Walker0low30
Cardiac Failure0low10
Carotid Circulation Transient Ischemic Attack0low10
Cells, Neoplasm Circulating0low30
Cephalgia, Vascular0low10
Cerebral Anoxia0low10
Cerebral Concussion0low10
Cerebral Edema0low10
Cerebral Edema, Cytotoxic0low10
Cerebral Edema, Vasogenic0low10
Cerebral Hypoxia0low10
Cerebral Ischemia0medium41
Cerebral Ischemia, Transient0low10
Cerebrovascular Diseases0medium104
Cerebrovascular Disorders0medium104
Cerebrovascular Insufficiency0medium104
Cerebrovascular Occlusion0medium104
Cervical Migraine Syndrome0low20
Chorangioma0low10
Chorioangioma0low10
Chronic Disease0medium72
Chronic Illness0medium72
Chronically Ill0medium72
Circulating Cells, Neoplasm0low30
Circulating Neoplastic Cells0low30
Circulating Tumor Cells0low30
Cirrhosis, Liver0low10
Classic Hemophilia0low10
Coagulation Disorders, Blood0low10
Coagulation, Disseminated Intravascular0low20
Colic0low10
Commotio Cerebri0low10
Concussion, Intermediate0low10
Concussion, Mild0low10
Concussion, Severe0low10
Congenital Heart Defect0low10
Congenital Heart Defects0low10
Congenital Heart Disease0low10
Congenital Thrombotic Thrombocytopenic Purpura0low10
Congenital Zika Syndrome0low10
Congenital Zika Virus Infection0low10
Congestive Heart Failure0low10
Consumption Coagulopathy0low20
Coronary Disease0low20
Coronary Heart Disease0low20
Crescendo Transient Ischemic Attacks0low10
Cytotoxic Brain Edema0low10
Cytotoxic Cerebral Edema0low10
Day Blindness0medium11
Defects, Congenital Heart0low10
Deficiency, Factor VIII0low10
Deficiency, Oxygen0low10
Delirium0low10
Delirium of Mixed Origin0low10
Dementia0low10
Depression0low10
Diabetes Mellitus0medium11
Diabetes Mellitus, Adult-Onset0medium11
Diabetes Mellitus, Ketosis-Resistant0medium11
Diabetes Mellitus, Maturity-Onset0medium11
Diabetes Mellitus, Non Insulin Dependent0medium11
Diabetes Mellitus, Non-Insulin-Dependent0medium11
Diabetes Mellitus, Noninsulin Dependent0medium11
Diabetes Mellitus, Noninsulin-Dependent0medium11
Diabetes Mellitus, Slow-Onset0medium11
Diabetes Mellitus, Stable0medium11
Diabetes Mellitus, Type 20medium11
Diabetes Mellitus, Type II0medium11
Diabetic Angiopathies0medium21
Diabetic Retinopathy0low10
Diabetic Vascular Complications0medium21
Diabetic Vascular Diseases0medium21
Disease Models, Animal0low20
Disorders, Blood Coagulation0low10
Disseminated Coagulation, Intravascular0low20
Disseminated Intravascular Coagulation0low20
Distorted Hearing0low10
Drug Overdose0low10
Dysacusis0low10
Edema, Pulmonary0low10
Edemas, Pulmonary0low10
Ehrlich Ascites Tumor0low10
Embolic Tumor Cells0low30
Embolism, Tumor0low30
Emergencies0low10
Encephalopathy, Hypoxic0low10
Encephalopathy, Ischemic0medium41
Epilepsy0low20
Epilepsy, Cryptogenic0low20
Experimental Neoplasms0low30
Extravascular Hemolysis0low10
Factor 8 Deficiency, Congenital0low10
Factor VIII Deficiency0low10
Factor VIII Deficiency, Congenital0low10
Familial Dementia0low10
Familial Thrombotic Thrombocytopenia Purpura0low10
Familial Thrombotic Thrombocytopenic Purpura0low10
Femoral Head, Avascular Necrosis Of0low10
Femur Head Necrosis0low10
Fever, Zika0low10
Fibrosis, Liver0low10
Focal Brain Injuries0low10
Frostbite0low10
Glaucoma0medium22
Granuloma, Hodgkin0low10
Granuloma, Hodgkin's0low10
Granuloma, Hodgkins0low10
Granuloma, Malignant0low10
Haemolysis0low10
Haemophilia0low10
Hallucination of Body Sensation0low10
Hallucinations0low10
Hallucinations, Auditory0low10
Hallucinations, Dissociative0low10
Hallucinations, Elementary0low10
Hallucinations, Formed, of People0low10
Hallucinations, Gustatory0low10
Hallucinations, Hypnagogic0low10
Hallucinations, Hypnapompic0low10
Hallucinations, Internal Body Sensation0low10
Hallucinations, Kinesthetic0low10
Hallucinations, Mood Congruent0low10
Hallucinations, Mood Incongruent0low10
Hallucinations, Olfactory0low10
Hallucinations, Organic0low10
Hallucinations, Reflex0low10
Hallucinations, Sensory0low10
Hallucinations, Somatic0low10
Hallucinations, Tactile0low10
Hallucinations, Verbal Auditory0low10
Hallucinations, Visual0low10
Hallucinations, Visual, Formed0low10
Hallucinations, Visual, Unformed0low10
HbS Disease0low10
Headache, Migraine0low20
Headache, Vascular0low10
Hearing Disorders0low10
Hearing Loss, Noise-Induced0medium11
Heart Abnormalities0low10
Heart Block0medium11
Heart Decompensation0low10
Heart Defect, Congenital0low10
Heart Defects, Congenital0low10
Heart Failure0low10
Heart Failure, Congestive0low10
Heart Failure, Left-Sided0low10
Heart Failure, Right-Sided0low10
Heart, Malformation Of0low10
Hemangioma0low10
Hemangioma, Histiocytoid0low10
Hemangioma, Intramuscular0low10
Hemeralopia0medium11
Hemicrania Migraine0low20
Hemoglobin S Disease0low10
Hemolysis0low10
Hemophilia0low10
Hemophilia A0low10
Hemophilia A, Congenital0low10
Hemophilia, Classic0low10
Hemophilia, Vascular0low10
Hepatic Cancer0low10
Hepatic Cirrhosis0low10
Hepatic Neoplasms0low10
Hepatocellular Cancer0low10
Hodgkin Disease0low10
Hodgkin Lymphoma0low10
Hodgkin Lymphoma, Adult0low10
Hodgkin's Disease0low10
Hodgkin's Lymphoma0low10
Hodgkins Disease0low10
Hyperglycemia0low10
Hyperglycemia, Postprandial0low10
Hypertension0low20
Hypertension, Renal0low10
Hypoxemia0low10
Hypoxia0low10
Hypoxia, Brain0low10
Hypoxia, Cerebral0low10
Hypoxic Brain Damage0low10
Hypoxic Encephalopathy0low10
Infantile Colic0low10
Injuries, Acute Brain0low10
Injuries, Brain0low10
Injury, Ischemia-Reperfusion0low10
Injury, Reperfusion0low10
Inner Ear Disease0medium11
Intermittent Claudication0medium43
Intestinal Diseases0low10
Intracranial Edema0low10
Intracranial Vascular Disorders0medium104
Intraocular Pressure0low10
Intravascular Coagulation, Disseminated0low20
Intravascular Disseminated Coagulation0low20
Intravascular Hemolysis0low10
Ischemia0medium31
Ischemia-Reperfusion Injury0low10
Ischemia, Cerebral0medium41
Ischemic Attack, Transient0low10
Ischemic Encephalopathy0medium41
Ischemic Necrosis Of Femoral Head0low10
Labyrinth Diseases0medium11
Left-Sided Heart Failure0low10
Leukemia P3880low10
Liver Cancer0low10
Liver Cirrhosis0low10
Liver Fibrosis0low10
Liver Neoplasms0low10
Long Sleeper Syndrome0low10
Lung Cancer0low10
Lung Neoplasms0low10
Lymphocyte Depletion Hodgkin's Lymphoma0low10
Lymphocyte-Rich Classical Hodgkin's Lymphoma0low10
Lymphogranuloma, Malignant0low10
Macropsia0medium11
Malignancy0low10
Malignant Neoplasms0low10
Maturity-Onset Diabetes0medium11
Maturity-Onset Diabetes Mellitus0medium11
Metamorphopsia0medium11
Metastase0low60
Metastases, Neoplasm0low60
Metastasis0low60
Metastasis, Neoplasm0low60
Microangiopathic Hemolytic Anemia, Congenital0low10
Microangiopathy, Diabetic0medium21
Micropsia0medium11
Migraine0low20
Migraine Disorders0low20
Migraine Headache0low20
Migraine Variant0low20
Mild Traumatic Brain Injury0low10
Mixed Cellularity Hodgkin's Lymphoma0low10
MODY0medium11
Moschcowitz Disease0low10
Moschkowitz Disease0low10
Muscle Contraction0low20
Myocardial Failure0low10
Necrosis, Aseptic, of Femur Head0low10
Necrosis, Avascular, of Femur Head0low10
Neoplasia0low10
Neoplasm0low10
Neoplasm Circulating Cells0low30
Neoplasm Metastases0low60
Neoplasm Metastasis0low60
Neoplasms0low10
Neoplasms, Benign0low10
Neoplasms, Experimental0low30
Neoplasms, Hepatic0low10
Neoplasms, Liver0low10
Neoplasms, Lung0low10
Neoplasms, Pulmonary0low10
Neoplastic Cells, Circulating0low30
NIDDM0medium11
Nodular Lymphocyte-Predominant Hodgkin's Lymphoma0low10
Nodular Sclerosing Hodgkin's Lymphoma0low10
Noninsulin-Dependent Diabetes Mellitus0medium11
Oxygen Deficiency0low10
P388D(1) Leukemia0low10
Paracousis0low10
Paracusis0low10
Paranoia0low10
Paranoid Disorders0low10
Paranoid Psychoses0low10
Poisoning0low10
Posterior Circulation Transient Ischemic Attack0low10
Postprandial Hyperglycemia0low10
Psychoses, Drug0low20
Psychoses, Paranoid0low10
Psychoses, Substance-Induced0low20
Psychoses, Toxic0low20
Pulmonary Cancer0low10
Pulmonary Edema0low10
Pulmonary Edemas0low10
Pulmonary Neoplasms0low10
Purpura, Thrombotic Thrombocytopenic0low10
Purpura, Thrombotic Thrombopenic0low10
Reperfusion Damage0low10
Reperfusion Injury0low10
Right-Sided Heart Failure0low10
Schulman-Upshaw Syndrome0low10
Seizure Disorder0low20
Senile Paranoid Dementia0low10
Shock, Cardiogenic0low10
Short Sleep Phenotype0low10
Short Sleeper Syndrome0low10
Sick Headache0low20
Sick Sinus Node Syndrome0medium11
Sick Sinus Syndrome0medium11
Sickle Cell Anemia0low10
Sickle Cell Disease0low10
Sickle Cell Disorders0low10
Sickling Disorder Due to Hemoglobin S0low10
Sinus Node Disease0medium11
Sinus Node Dysfunction0medium11
Sleep Disorders0low10
Sleep Wake Disorders0low10
Sleep-Related Neurogenic Tachypnea0low10
Status Migrainosus0low20
Stenocardia0low20
Subacute Delirium0low10
Substance-Induced Psychoses0low20
Subwakefullness Syndrome0low10
Thrombocytopathy0low20
Thrombocytopenia0low10
Thrombopenia0low10
Thrombosis0medium31
Thrombotic Microangiopathy, Familial0low10
Thrombotic Thrombocytopenic Purpura0low10
Thrombotic Thrombocytopenic Purpura, Congenital0low10
Thrombotic Thrombocytopenic Purpura, Familial0low10
Thrombus0medium31
TIA (Transient Ischemic Attack)0low10
Toxic Psychoses0low20
Transient Ischemic Attack0low10
Transient Ischemic Attack, Anterior Circulation0low10
Transient Ischemic Attack, Brain Stem0low10
Transient Ischemic Attack, Brainstem0low10
Transient Ischemic Attack, Carotid Circulation0low10
Transient Ischemic Attack, Posterior Circulation0low10
Transient Ischemic Attack, Vertebrobasilar Circulation0low10
Transient Ischemic Attacks, Crescendo0low10
Tumor Cells, Embolic0low30
Tumors0low10
Type 2 Diabetes0medium11
Type 2 Diabetes Mellitus0medium11
Upshaw Factor, Deficiency of0low10
Upshaw-Schulman Syndrome0low10
Uremia0low10
Ureteral Diseases0low10
Vascular Diseases0low10
Vascular Diseases, Intracranial0medium104
Vascular Headache0low10
Vascular Headaches0low10
Vascular Pseudohemophilia0low10
Vasogenic Brain Edema0low10
Vasogenic Cerebral Edema0low10
Vertebrobasilar Circulation Transient Ischemic Attack0low10
Vision Disability0medium11
Vision Disorders0medium11
Visual Disorders0medium11
Visual Impairment0medium11
von Willebrand Disease0low10
von Willebrand Disease, Recessive Form0low10
von Willebrand Diseases0low10
Von Willebrand Disorder0low10
von Willebrand's Disease0low10
von Willebrand's Diseases0low10
Von Willebrand's Factor Deficiency0low10
Wet Lung0low10
Zika Fever0low10
Zika Virus Disease0low10
Zika Virus Infection0low10
ZikV Infection0low10

Research Highlights

Pharmacokinetics (3)

ArticleYear
Pharmacokinetics of bencyclane after single dose administration to healthy volunteers.
Arzneimittel-Forschung, Volume: 35, Issue: 10		1985
Gas-liquid chromatographic evaluation of bencyclane in biological samples for pharmacokinetic and bioavailability investigations: comparison of two analytical methods.
Journal of chromatography, Sep-13, Volume: 343, Issue: 1		1985
A contribution to the pharmacokinetics of bencyclane (Fludilat) in man.
International journal of clinical pharmacology and biopharmacy, Volume: 13, Issue: 4		1976
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioavailability (3)

ArticleYear
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
The Journal of biological chemistry, 11-15, Volume: 294, Issue: 46		2019
Pharmacokinetics of bencyclane after single dose administration to healthy volunteers.
Arzneimittel-Forschung, Volume: 35, Issue: 10		1985
Gas-liquid chromatographic evaluation of bencyclane in biological samples for pharmacokinetic and bioavailability investigations: comparison of two analytical methods.
Journal of chromatography, Sep-13, Volume: 343, Issue: 1		1985
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Dosage (4)

ArticleYear
[Halidor in the treatment of cerebral vascular diseases in emergency cases].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, Volume: 108, Issue: 12		2008
Pial arteriolar reaction to intravenous administration of bencyclane in the cat.
European neurology, Volume: 19, Issue: 1		1980
Radioimmunoassay of bencyclane in human serum.
Journal of pharmacobio-dynamics, Volume: 8, Issue: 3		1985
The metabolism of benzyclane [1-benzyl-1-(3-N,N-dimethylaminopropoxy)cycloheptane] in rat and man.
Xenobiotica; the fate of foreign compounds in biological systems, Volume: 9, Issue: 2		1979
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]